Vedolizumab SC: Clinical Trials

6 completed, 3 recruiting. 5 Phase 1, 3 Phase 3, 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 1	5	Completed 5
Phase 3	3	Recruiting 2, Completed 1
Phase 4	1	Recruiting 1

Follow Vedolizumab SC: new trials by email Literature Review of Vedolizumab SC trials Research Report on Vedolizumab SC

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) Vedolizumab SC, No Intervention - Ulcerative Colitis, Crohn's Disease	Phase 3	Recruiting	Takeda	70	2025-10-27	2026-10-09
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting Vedolizumab IV, Vedolizumab SC - Ulcerative Colitis, Crohn's Disease	Phase 4	Recruiting	Takeda	200	2025-03-27	2026-10-20
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Vedolizumab IV, Vedolizumab SC - Ulcerative Colitis, Crohn's Disease	Phase 3	Recruiting	Takeda	70	2025-01-22	2026-08-03
A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants Vedolizumab SC - Healthy Volunteers	Phase 1	Completed	Takeda	204	2018-03-12	2019-11-14
A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants Vedolizumab SC - Healthy Volunteers	Phase 1	Completed	Takeda	24	2018-02-22	2019-11-13
A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants Vedolizumab SC - Healthy Volunteers	Phase 1	Completed	Takeda	102	2018-02-21	2022-07-29
A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants Vedolizumab SC - Healthy Volunteers	Phase 1	Completed	Takeda	24	2018-02-06	2019-11-13
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease Vedolizumab SC - Colitis, Ulcerative, Crohn's Disease	Phase 3	Completed	Takeda	746	2016-04-15	2025-04-03
Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration Vedolizumab SC, Vedolizumab IV - Healthy	Phase 1	Completed	Takeda	48	2014-06-01	2017-02-01

Conditions studied

Colitis, Ulcerative (4)  ·  Crohn Disease (4)

Sponsors

Takeda (9)

Countries

United States (8)  ·  Belgium (3)  ·  Bulgaria (3)  ·  Italy (3)  ·  Japan (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Romania (3)  ·  Serbia (3)  ·  South Korea (3)  ·  Spain (3)  ·  Taiwan (3)  ·  Denmark (2)  ·  Ireland (2)  ·  Switzerland (2)

Results publications

PMID 37492976

NIH funding

2023 (2), 2014 (1), 2015 (1)